Lin Liu Selected Research

Long Noncoding RNA

1/2022	Regulation of influenza A virus infection by Lnc-PINK1-2:5.
1/2022	LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
1/2022	BMSC-EV-derived lncRNA NORAD Facilitates Migration, Invasion, and Angiogenesis in Osteosarcoma Cells by Regulating CREBBP via Delivery of miR-877-3p.
1/2022	Matrine exerted an anti-tumor effect on acute myeloid leukemia via the lncRNA LINC01116/miR-592-mediated JAK/STAT pathway inactivation.
10/2021	Retraction Note: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
10/2021	Plasmonically Enhanced CRISPR/Cas13a-Based Bioassay for Amplification-Free Detection of Cancer-Associated RNA.
6/2021	Correction to: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
6/2021	Uncovering the roles of microRNAs/lncRNAs in characterising breast cancer subtypes and prognosis.
4/2021	A high level of lncFGD5-AS1 inhibits epithelial-to-Mesenchymal transition by regulating the miR-196a-5p/SMAD6/BMP axis in gastric Cancer.
1/2021	Long Non-Coding RNA CD27-AS1-208 Facilitates Melanoma Progression by Activating STAT3 Pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Liu Research Topics

Disease

224	Neoplasms (Cancer) 02/2023 - 08/2003
71	Infections 04/2022 - 03/2004
51	Inflammation (Inflammations) 06/2022 - 08/2010
38	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2004
32	Pain (Aches) 06/2022 - 11/2007
32	Carcinogenesis 01/2022 - 08/2003
30	Neoplasm Metastasis (Metastasis) 09/2022 - 12/2003
24	Stroke (Strokes) 12/2022 - 02/2003
23	Fibrosis (Cirrhosis) 01/2022 - 10/2010
21	Carcinoma (Carcinomatosis) 11/2021 - 03/2004
20	Wounds and Injuries (Trauma) 07/2021 - 01/2009
19	Type 2 Diabetes Mellitus (MODY) 08/2022 - 05/2012
18	Body Weight (Weight, Body) 01/2022 - 11/2010
18	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2008
17	Hypertension (High Blood Pressure) 06/2022 - 09/2011
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2012
16	Melanoma (Melanoma, Malignant) 01/2022 - 10/2012
15	Chronic Obstructive Pulmonary Disease (COPD) 07/2022 - 01/2007
14	Leukemia 10/2021 - 04/2004
14	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 09/2006
14	Ischemia 01/2019 - 04/2012
13	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2007
13	Hypoxia (Hypoxemia) 01/2022 - 10/2014
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 04/2004
13	Stomach Neoplasms (Stomach Cancer) 12/2021 - 12/2008
12	Necrosis 07/2022 - 12/2003
12	Insulin Resistance 01/2022 - 06/2014
12	Reperfusion Injury 01/2020 - 01/2013
11	COVID-19 11/2022 - 01/2020
11	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 04/2005
11	Ischemic Stroke 01/2021 - 02/2003
11	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020 - 01/2009
10	Human Influenza (Influenza) 12/2022 - 12/2014
10	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 10/2010
10	Myocardial Infarction 01/2021 - 01/2012
10	Heart Failure 01/2021 - 04/2008
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2004
9	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 11/2011
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2003
8	Parkinson Disease (Parkinson's Disease) 10/2022 - 09/2010
8	Pneumonia (Pneumonitis) 08/2022 - 06/2010
8	Disease Progression 07/2022 - 02/2008
8	Rheumatoid Arthritis 07/2022 - 12/2014
8	Schizophrenia (Dementia Praecox) 01/2022 - 08/2008
8	Hemorrhage 12/2021 - 04/2013
8	Asthma (Bronchial Asthma) 10/2021 - 03/2003
8	Virus Diseases (Viral Diseases) 10/2021 - 11/2010
8	Atherosclerosis 02/2021 - 02/2013
8	Glioma (Gliomas) 01/2020 - 09/2005
8	Chromosomal Instability (Chromosome Stability) 01/2018 - 08/2003

Drug/Important Bio-Agent (IBA)

91	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2003
61	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2007
50	Biomarkers (Surrogate Marker)IBA 09/2022 - 06/2008
47	Pharmaceutical PreparationsIBA 02/2023 - 03/2003
33	Messenger RNA (mRNA)IBA 04/2022 - 12/2003
31	CytokinesIBA 07/2022 - 09/2008
28	Long Noncoding RNAIBA 01/2022 - 08/2014
27	Biological ProductsIBA 06/2022 - 03/2008
21	Therapeutic UsesIBA 01/2022 - 08/2003
21	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2008
21	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 09/2011
19	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2008
18	EnzymesIBA 08/2021 - 03/2013
17	AntigensIBA 01/2022 - 12/2008
16	Retinaldehyde (Retinal)IBA 01/2022 - 04/2005
16	Peptides (Polypeptides)IBA 07/2021 - 04/2010
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2011
13	Interleukin-6 (Interleukin 6)IBA 04/2022 - 01/2013
13	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 09/2002
13	Phosphotransferases (Kinase)IBA 01/2020 - 09/2012
12	VaccinesIBA 11/2022 - 05/2012
12	Blood Glucose (Blood Sugar)IBA 09/2022 - 05/2012
12	LigandsIBA 04/2022 - 01/2013
12	CollagenIBA 01/2022 - 06/2014
12	LipidsIBA 01/2022 - 01/2007
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2012
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2014
11	Small Interfering RNA (siRNA)IBA 02/2021 - 05/2008
10	Amyloid (Amyloid Fibrils)IBA 07/2021 - 12/2006
10	Oxygen (Dioxygen)IBA 01/2018 - 11/2003
9	InterferonsIBA 07/2022 - 04/2013
9	AntioxidantsIBA 05/2022 - 10/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2014
9	CholesterolIBA 12/2021 - 05/2012
9	Chimeric Antigen ReceptorsIBA 10/2021 - 03/2012
9	CreatinineIBA 09/2021 - 12/2010
8	Indicators and Reagents (Reagents)IBA 08/2022 - 11/2010
8	Insulin (Novolin)FDA Link 02/2022 - 06/2014
8	Estrogen ReceptorsIBA 01/2022 - 02/2012
8	CateninsIBA 10/2021 - 11/2015
8	oxidized low density lipoproteinIBA 01/2021 - 11/2011
8	salicylhydroxamic acid (SHAM)IBA 11/2019 - 04/2008

Therapy/Procedure

105	Therapeutics 07/2022 - 08/2003
40	Drug Therapy (Chemotherapy) 06/2022 - 01/2005
17	Radiotherapy 05/2022 - 04/2006
12	Immunotherapy 05/2022 - 03/2012
10	Length of Stay 12/2021 - 05/2012
10	Transplantation 01/2021 - 12/2011
9	Hematopoietic Stem Cell Transplantation 02/2022 - 11/2007
9	Aftercare (After-Treatment) 02/2022 - 09/2011